Results 111 to 120 of about 21,198 (196)

Nudging epidermal field cancerogenesis by imiquimod.

, 2003
peer reviewedBACKGROUND: The coexistence of malignancies close to each other on the skin has been occasionally reported. The concept of field cancerogenesis applies to such cases.
Uhoda, Isabelle, Pierard, Gérald, Quatresooz, Pascale, Pierard, Claudine   +3 more
core   +1 more source

Medication prescription patterns in cancer rehabilitation physiatry outpatients: A multicenter retrospective study

PM&R, Volume 18, Issue 9, Page 1005-1015, September 2026.
Abstract Background and Objective Previous work from this dataset found 45% prescribing frequency of any medications (35.1%, 33.5%, and 56.8% at institutions 1, 2, and 3 respectively), without significant difference between in‐person and telemedicine.
Matthew Chen, Nafis Eghrari, David Leong, Philip Chang, Jasmine Zheng, Amy Ng, Richard Wilson, Mary Vargo   +7 more
wiley   +1 more source

Recurrence Rates of Incompletely Excised Primary Basal Cell Carcinoma Treated With Mohs Micrographic Surgery and Radiotherapy

Australasian Journal of Dermatology, Volume 67, Issue 6, Page e348-e352, September 2026.
ABSTRACT Background/Objectives Incompletely excised primary basal cell carcinoma (pBCC) is a frequently encountered scenario in clinical practice, yet the significance of the phenomenon is not well described in current literature. Re‐excision is recommended for high‐risk incompletely excised pBCCs, but recurrence rates post re‐excision of pBCCs with ...
Georgia De'Ambrosis, Brian De'Ambrosis, Perry Wilson, Alexander Coe   +3 more
wiley   +1 more source

Efficacy and Safety of Anal High‐Grade Squamous Intraepithelial Lesion Treatment Modalities: A Systematic Review

ANZ Journal of Surgery, Volume 96, Issue 9, Page 2339-2352, September 2026.
ABSTRACT Background There is compelling evidence that treating high‐grade squamous intraepithelial lesions (HSIL), the anal squamous cell cancer (ASCC) precursor, reduces the risk of developing ASCC. Using high‐resolution anoscopy (HRA), surgical excision, ablative and topical therapies are widely used to treat HSIL.
Matthew Joseph Marino, Sophie Jones, Nicholas Reid Caldwell, Catherine Cartwright, Benedict Blacket, Richard Clive Turner   +5 more
wiley   +1 more source

Advances in the use of topical imiquimod to treat dermatologic disorders

, 2008
Francesco Lacarrubba, Maria Rita Nasca, Giuseppe MicaliDermatology Clinic, University of Catania, ItalyAbstract: Imiquimod (IQ) is an immune-response modifying agent, first approved by FDA for the topical treatment of external genital and perianal warts ...
Giuseppe Micali, Francesco Lacarrubba, Maria Rita Nasca   +2 more
core  

Chronic Ulcer on the Vulva

JEADV Clinical Practice, Volume 5, Issue 3, Page 1010-1012, September 2026.
Farhanaz Panjshiri, Reed Gioe, Carole Bitar   +2 more
wiley   +1 more source

Rare Secondary Neoplasms Arising in Epidermal Nevus: A Case Series and Literature Review

Journal of Cutaneous Pathology, Volume 53, Issue 9, Page 772-782, September 2026.
ABSTRACT Malignant transformation is known to occur with many nevi, such as nevus sebaceus. However, cases of secondary tumors developing in an epidermal nevus (EN) are rare, with only a few case reports documented in the literature. We present three unique cases of syringocystadenoma papilliferum (SCAP), syringofibroadenoma, trichilemmoma, and basal ...
Haya A. Homsi, Melissa Piliang, Jennifer Lucas, Jennifer S. Ko, Steven D. Billings, Shira Ronen   +5 more
wiley   +1 more source

Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts--results of an open-label, multicentre Phase IIIB trial

, 2001
Our objective was to determine the efficacy and safety of imiquimod 5% cream in the treatment of external genital/perianal warts in an open-label Phase IIIB trial. Patients applied imiquimod 5% cream 3 times per week, for up to 16 weeks.
Garland, SM, Aranda, C, Imiquimod, Study Group, Aractingi, S, Wikstrom, A, Petersen, CS, Sellors, JW, Maw, RD   +7 more
core   +1 more source

Immunotherapy with imiquimod in cervical, vaginal, and vulvar intraepithelial lesions – a review of the literature

Libri Oncologici
Imiquimod is a topical immunomodulatory agent commonly used in treating various skin conditions, including precancerous lesions. This review summarizes current evidence on the efficacy and safety of imiquimod for treating vaginal, cervical, and vulvar ...
Damir Danolić, Luka Marcelić, Lucija Šušnjar, Ilija Alvir, Ivica Mamić, Domagoj Dobranić, Darko Tomica, Tomislav Bečejac, Domagoj Vidosavljević, Mario Puljiz   +9 more
doaj   +1 more source

Treatments for molluscum contagiosum: A systematic review

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 9, Page e1204-e1211, September 2026.
Summary Molluscum contagiosum (MC) is a viral skin infection that poses significant physical and psychosocial burdens, particularly in pediatric and immunocompromised populations. Despite the availability of various treatment options, comparative efficacy and safety data remain limited.
Ou Jia (Emilie) Wang, Mahek Shergill, Ammar Saed Aldien, Ilya Mukovozov   +3 more
wiley   +1 more source